Advertisement
Singapore markets closed

  • Straits Times Index

    3,280.10
    -7.65 (-0.23%)
     

  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     

  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     

  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     

  • Bitcoin USD

    63,579.30
    -763.31 (-1.19%)
     

  • CMC Crypto 200

    1,328.44
    -68.09 (-4.88%)
     

  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     

  • Dow

    38,239.66
    +153.86 (+0.40%)
     

  • Nasdaq

    15,927.90
    +316.14 (+2.03%)
     

  • Gold

    2,349.60
    +7.10 (+0.30%)
     

  • Crude Oil

    83.66
    +0.09 (+0.11%)
     

  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     

  • FTSE Bursa Malaysia

    1,575.16
    +5.91 (+0.38%)
     

  • Jakarta Composite Index

    7,036.08
    -119.22 (-1.67%)
     

  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

Tokyo prosecutors raid Novartis Japan unit over clinical data probe

Reuters

TOKYO (Reuters) - Tokyo prosecutors on Thursday raided the Japanese unit of Novartis AG (NOVN.VX) on suspicion of manipulating data to promote the Swiss drugmaker's best-selling blood pressure drug Diovan, a local Novartis spokeswoman said.

The raid comes a day after prosecutors arrested a former employee at Novartis Pharma K.K., the unlisted Japanese subsidiary, in the same case of suspected violation of laws that prohibit exaggerated advertising.

The spokeswoman repeated the company's statement a day earlier that Novartis took the matter seriously and that it would continue to cooperate with the investigating authorities.

(Reporting by Chang-Ran Kim; Editing by Chris Gallagher)